1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Clonal haematopoiesis and risk of chronic liver disease
(
- Contribution to journal › Article
-
Mark
Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke
(
- Contribution to journal › Article
-
Mark
Circulating Metabolomic and Lipidomic Signatures Identify a Type 2 Diabetes Risk Profile in Low-Birth-Weight Men with Non-Alcoholic Fatty Liver Disease
(
- Contribution to journal › Article
- 2022
-
Mark
Intestinal gluconeogenesis is downregulated in pediatric patients with celiac disease
(
- Contribution to journal › Article
- 2021
-
Mark
MAFLD and risk of CKD
(
- Contribution to journal › Article
-
Mark
The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
(
- Contribution to journal › Article
- 2020
-
Mark
The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue
(
- Contribution to journal › Article
-
Mark
Association between NAFLD and risk of prevalent chronic kidney disease : Why there is a difference between east and west?
(
- Contribution to journal › Article
-
Mark
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD
(
- Contribution to journal › Article
-
Mark
PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels
(
- Contribution to journal › Article